Lysoway Therapeutics United States

Lysoway Therapeutics is an emerging biopharmaceutical company focusing on restoring or enhancing autophagy and lysosomal functions to treat a broad class of diseases.
Website:
www.lysoway.com
Company Size (Fulltime employees)
Year of foundation
2020
Please specify your partnering goal
Looking for investors who share the same passion on developing novel therapeutics to treat a variety of diseases
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Dr. Yongchang Qiu
Founder and Chief Executive Officer 
Functionality

Medical/Legal Genetics inc United States

A CAP, CLIA And AABB certified clinical lab specialized in genetic and molecular diagnosis
Website:
1800dnagenes.com
Company Size (Fulltime employees)
Year of foundation
1958
Please specify your partnering goal
Similar field
Headquartner in China
Biotech/Pharma Category
Medtech Category
Dr. Helen Hua
MD, MS, MT(ASCP) 
Functionality

Satyarx Pharma Innovations Private Limited India

Satya is an early-stage Oncology biotech focused on discovering small molecule NCEs, with novel targets against well-established Oncogenes, Tumor suppressors and Synthetic Lethal targets. Satya's team has over 50 years' combined discovery expertise, having worked on over 75 targets and delivered 15 clinical candidates
Website:
www.satyarx.com
Company Size (Fulltime employees)
Year of foundation
2019
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Mr Murthy Chavali
LinkedIn logo CEO 
Functionality